Twist Bioscience Corp
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30.9% | -32.1% | -25.8% | -7.8% | -18.1% | -24.2% | -14.0% | -1.5% | -11.9% | -23.9% | -15.9% | 0.9% | -12.3% | |
| 12.7% | 11.4% | 11.0% | 10.2% | 7.9% | 7.2% | 6.9% | 6.3% | 6.1% | 6.0% | 5.8% | 5.7% | 5.9% | |
| 17.5% | 15.4% | 18.4% | 16.9% | 14.6% | 13.5% | 21.9% | 16.7% | 16.2% | 12.8% | 17.1% | 15.4% | 15.4% | |
| 0.7% | 0.7% | 4.6% | 15.4% | -1.3% | -9.2% | -1.3% | 3.9% | -7.1% | -13.0% | 1.5% | 2.8% | -3.6% | |
| 3.6% | 2.1% | 0.8% | 1.2% | 2.4% | 2.6% | 4.5% | 9.5% | 12.6% | 9.6% | 7.2% | 8.2% | 9.3% | |
| -3.4% | 5.8% | -7.0% | -0.9% | -1.5% | -1.7% | -1.5% | -9.8% | -12.5% | -9.6% | -11.5% | -8.6% | -10.5% | |
| -1.7% | -3.4% | -2.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 0.7% | -2.1% | 2.4% | 3.6% | 4.3% | 20.2% | 3.4% | 1.9% | 5.6% | 0.3% | 3.7% | 3.2% | 3.2% | |
| -33.7% | -28.2% | -30.4% | -5.1% | -15.2% | -5.7% | -12.0% | -9.4% | -18.7% | -33.2% | -23.6% | -4.5% | -19.5% | |
| -34.5% | -34.2% | -26.6% | -9.0% | -20.4% | -26.7% | -18.5% | -11.0% | -24.5% | -33.5% | -23.1% | -7.2% | -21.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.